460.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALNY Giù?
Forum
Previsione
Alnylam Pharmaceuticals Inc Borsa (ALNY) Ultime notizie
Is Alnylam Pharmaceuticals Inc. stock cheap at current valuation2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Why Alnylam Pharmaceuticals Inc. (DUL) stock attracts wealthy investors2025 Price Action Summary & Verified Technical Signals - newser.com
How Alnylam Pharmaceuticals Inc. (DUL) stock reacts to fiscal policiesWeekly Trading Summary & Real-Time Volume Analysis - newser.com
Is Alnylam Pharmaceuticals Inc. stock a defensive play in 2025Trade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
Regression analysis insights on Alnylam Pharmaceuticals Inc. performance2025 Top Gainers & Reliable Volume Spike Alerts - newser.com
Will Alnylam Pharmaceuticals Inc. continue its uptrendEarnings Miss & Smart Money Movement Tracker - newser.com
Will Alnylam Pharmaceuticals Inc. (DUL) stock sustain bullish trend into 2025Portfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Will Alnylam Pharmaceuticals Inc. stock deliver consistent dividends2025 Macro Impact & Short-Term High Return Strategies - newser.com
How risky is Alnylam Pharmaceuticals Inc. (DUL) stock compared to peers2025 Top Decliners & Expert Approved Trade Ideas - newser.com
Transcript : Alnylam Pharmaceuticals, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-19-2025 11 - MarketScreener
Is Alnylam Pharmaceuticals Inc. (DUL) stock a fit for income portfolios2025 Price Targets & Smart Swing Trading Techniques - newser.com
What data driven models say about Alnylam Pharmaceuticals Inc.’s futureVolume Spike & Fast Moving Stock Watchlists - newser.com
How to recover losses in Alnylam Pharmaceuticals Inc. stockPortfolio Update Report & Verified Momentum Stock Alerts - newser.com
Alnylam Pharmaceuticals Faces Weak Start with 6.56% Gap Down Amid Market Concerns - Markets Mojo
How institutional buying supports Alnylam Pharmaceuticals Inc. stockPortfolio Update Summary & Real-Time Volume Analysis - newser.com
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain institutional flowsJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com
Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation - Yahoo Finance
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Alnylam Pharmaceuticals (ALNY): Assessing Valuation Following Positive HELIOS-B Data on Vutrisiran Efficacy - simplywall.st
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain revenue momentumJuly 2025 Sentiment & Smart Money Movement Alerts - newser.com
Alnylam, MongoDB, Quanta Services, 11 Others Join IBD Watchlists - Investor's Business Daily
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):